465 related articles for article (PubMed ID: 6609234)
1. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
2. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
3. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
5. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
6. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
7. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
Maddison PJ; Mogavero H; Reichlin M
J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of screening for antibody to ribonucleoprotein.
Small P; Barrett D; Champlin E
Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
10. Antibody to extractable nuclear antigen in the rheumatic diseases.
McCain GA; Bell DA; Chodirker WB; Komar RR
J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
[TBL] [Abstract][Full Text] [Related]
11. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
Ramos-Niembro F; Alarcon-Segovia D
J Rheumatol; 1978; 5(4):433-40. PubMed ID: 310886
[TBL] [Abstract][Full Text] [Related]
12. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
14. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
18. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of ribonucleoprotein antibody.
Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
Lemmer JP; Curry NH; Mallory JH; Waller MV
J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
